Altogether, these data supported the lineage relationship between tumor-infiltrating CD16+ and CD16- CD103+ NK cells in human breast tumors, both subsets capable of CCL5/IFN-ɣ production. This evidence concerns the gene CCL5 and breast neoplasm.